{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:41Z","timestamp":1787003741717,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81526-4","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:39:02Z","timestamp":1732840742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-7155","authenticated-orcid":false,"given":"Matteo","family":"Foschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-4031","authenticated-orcid":false,"given":"Raffaele","family":"Ornello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-6427","authenticated-orcid":false,"given":"Federico","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0393-2956","authenticated-orcid":false,"given":"Francesca","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-8543","authenticated-orcid":false,"given":"Michele","family":"Romoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Conversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-7000","authenticated-orcid":false,"given":"Federica","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5463-8809","authenticated-orcid":false,"given":"Berardino","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1939","authenticated-orcid":false,"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"6","key":"81526_CR1","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/cns.14175","volume":"29","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage. CNS Neurosci. Ther. 29 (6), 1484\u20131496. https:\/\/doi.org\/10.1111\/cns.14175 (2023).","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"81526_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.295.3.306","volume":"295","author":"J S Berger","year":"2006","unstructured":"Berger JS, R. et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 295 (3), 306\u2013313. https:\/\/doi.org\/10.1001\/jama.295.3.306 (2006).","journal-title":"JAMA"},{"issue":"9678","key":"81526_CR3","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, B. et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 373 (9678), 1849\u20131860. https:\/\/doi.org\/10.1016\/S0140-6736(09)60503-1 (2009).","journal-title":"Lancet"},{"issue":"13","key":"81526_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk, J. et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33 (13), 1635\u20131701. https:\/\/doi.org\/10.1093\/eurheartj\/ehs092 (2012).","journal-title":"Eur. Heart J."},{"issue":"29","key":"81526_CR5","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli, M. F. et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 37 (29), 2315\u20132381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106 (2016).","journal-title":"Eur. Heart J."},{"issue":"34","key":"81526_CR6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42 (34), 3227\u20133337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484 (2021).","journal-title":"Eur. Heart J."},{"issue":"2","key":"81526_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jacc.2014.10.035","volume":"65","author":"RS Hira","year":"2015","unstructured":"Hira, R. S. et al. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry\u2019s Practice Innovation and Clinical Excellence registry. J. Am. Coll. Cardiol. 65 (2), 111\u2013121. https:\/\/doi.org\/10.1016\/j.jacc.2014.10.035 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"81526_CR8","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1111\/bcp.13355","volume":"83","author":"I Ardoino","year":"2017","unstructured":"Ardoino, I. et al. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people. Br. J. Clin. Pharmacol. 83 (11), 2528\u20132540. https:\/\/doi.org\/10.1111\/bcp.13355 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"15","key":"81526_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181f735e5","volume":"75","author":"BB Thompson","year":"2010","unstructured":"Thompson, B. B. et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 75 (15), 1333\u20131342. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f735e5 (2010).","journal-title":"Neurology"},{"issue":"2","key":"81526_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000177924","volume":"27","author":"K Toyoda","year":"2009","unstructured":"Toyoda, K. et al. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The bleeding with antithrombotic therapy (BAT) retrospective study. Cerebrovasc. Dis. 27 (2), 151\u2013159. https:\/\/doi.org\/10.1159\/000177924 (2009).","journal-title":"Cerebrovasc. Dis."},{"key":"81526_CR11","doi-asserted-by":"publisher","first-page":"691357","DOI":"10.3389\/fneur.2021.691357","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Effects of prior antiplatelet therapy on Mortality, Functional Outcome, and Hematoma Expansion in Intracerebral Hemorrhage: an updated systematic review and Meta-analysis of Cohort studies. Front. Neurol. 12, 691357. https:\/\/doi.org\/10.3389\/fneur.2021.691357 (2021).","journal-title":"Front. Neurol."},{"issue":"8","key":"81526_CR12","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.STR.0000231842.32153.74","volume":"37","author":"C Foerch","year":"2006","unstructured":"Foerch, C., Sitzer, M., Steinmetz, H. & Neumann-Haefelin, T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 37 (8), 2165\u20132167. https:\/\/doi.org\/10.1161\/01.STR.0000231842.32153.74 (2006).","journal-title":"Stroke"},{"key":"81526_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2019.12.016","volume":"75","author":"L Franco","year":"2020","unstructured":"Franco, L. et al. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy. Eur. J. Intern. Med. 75, 35\u201343. https:\/\/doi.org\/10.1016\/j.ejim.2019.12.016 (2020).","journal-title":"Eur. J. Intern. Med."},{"issue":"9","key":"81526_CR14","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1161\/STROKEAHA.118.022161","volume":"49","author":"V Feigin","year":"2018","unstructured":"Feigin, V., Norrving, B., Sudlow, C. L. M. & Sacco, R. L. Updated Criteria for Population-based stroke and transient ischemic attack incidence studies for the 21st Century. Stroke 49 (9), 2248\u20132255. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022161 (2018).","journal-title":"Stroke"},{"issue":"7","key":"81526_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.str.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott, T. et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (7), 864\u2013870. https:\/\/doi.org\/10.1161\/01.str.20.7.864 (1989).","journal-title":"Stroke"},{"issue":"8","key":"81526_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/01.str.27.8.1304","volume":"27","author":"RU Kothari","year":"1996","unstructured":"Kothari, R. U. et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27 (8), 1304\u20131305. https:\/\/doi.org\/10.1161\/01.str.27.8.1304 (1996).","journal-title":"Stroke"},{"key":"81526_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(12)70038-8","volume":"11","author":"AM Demchuk","year":"2012","unstructured":"Demchuk, A. M. et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 11, 307\u2013314. https:\/\/doi.org\/10.1016\/S1474-4422(12)70038-8 (2012).","journal-title":"Lancet Neurol."},{"key":"81526_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.curtheres.2014.02.002","volume":"76","author":"J Lee","year":"2014","unstructured":"Lee, J. et al. Recovery time of platelet function after aspirin withdrawal. Curr. Ther. Res. Clin. Exp. 76, 26\u201331. https:\/\/doi.org\/10.1016\/j.curtheres.2014.02.002 (2014).","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"2","key":"81526_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/ene.13193","volume":"24","author":"P Camps-Renom","year":"2017","unstructured":"Camps-Renom, P. et al. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis. Eur. J. Neurol. 24 (2), 302\u2013308. https:\/\/doi.org\/10.1111\/ene.13193 (2017).","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"81526_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00415-008-0650-z","volume":"255","author":"HC Hanger","year":"2008","unstructured":"Hanger, H. C. et al. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J. Neurol. 255 (3), 347\u2013352. https:\/\/doi.org\/10.1007\/s00415-008-0650-z (2008).","journal-title":"J. Neurol."},{"issue":"9","key":"81526_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1212\/WNL.0000000000003659","volume":"88","author":"J Roquer","year":"2017","unstructured":"Roquer, J. et al. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage. Neurology 88 (9), 885\u2013891. https:\/\/doi.org\/10.1212\/WNL.0000000000003659 (2017).","journal-title":"Neurology"},{"key":"81526_CR22","doi-asserted-by":"publisher","first-page":"k2562","DOI":"10.1136\/bmj.k2562","volume":"362","author":"JY Ho","year":"2018","unstructured":"Ho, J. Y. & Hendi, A. S. Recent trends in life expectancy across high income countries: retrospective observational study. BMJ 362, k2562. https:\/\/doi.org\/10.1136\/bmj.k2562 (2018).","journal-title":"BMJ"},{"issue":"8","key":"81526_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/01.CIR.0000088843.52678.8A","volume":"108","author":"AI Schafer","year":"2003","unstructured":"Schafer, A. I. Genetic and acquired determinants of individual variability of response to antiplatelet drugs. Circulation 108 (8), 910\u2013911. https:\/\/doi.org\/10.1161\/01.CIR.0000088843.52678.8A (2003).","journal-title":"Circulation"},{"issue":"8","key":"81526_CR24","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1161\/STROKEAHA.120.030558","volume":"52","author":"SJGC Welten","year":"2021","unstructured":"Welten, S. J. G. C. et al. Age at menopause and risk of ischemic and Hemorrhagic Stroke. Stroke 52 (8), 2583\u20132591. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030558 (2021).","journal-title":"Stroke"},{"issue":"1","key":"81526_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","volume":"79","author":"K Toyoda","year":"2022","unstructured":"Toyoda, K. et al. Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes. JAMA Neurol. 79 (1), 61\u201369. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4346 (2022).","journal-title":"JAMA Neurol."},{"issue":"1","key":"81526_CR26","doi-asserted-by":"publisher","first-page":"2176173","DOI":"10.1080\/09537104.2023.2176173","volume":"34","author":"A Gasecka","year":"2023","unstructured":"Gasecka, A., Zimodro, J. M. & Appelman, Y. Sex differences in antiplatelet therapy: state-of-the art. Platelets 34 (1), 2176173. https:\/\/doi.org\/10.1080\/09537104.2023.2176173 (2023).","journal-title":"Platelets"},{"issue":"4","key":"81526_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000094604","volume":"22","author":"G Baldi","year":"2006","unstructured":"Baldi, G. et al. Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc. Dis. 22 (4), 286\u2013293. https:\/\/doi.org\/10.1159\/000094604 (2006).","journal-title":"Cerebrovasc. Dis."},{"issue":"10093","key":"81526_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","volume":"390","author":"L Li","year":"2017","unstructured":"Li, L., Geraghty, O. C., Mehta, Z. & Rothwell, P. M. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet 390 (10093), 490\u2013499. https:\/\/doi.org\/10.1016\/S0140-6736(17)30770-5 (2017).","journal-title":"Lancet"},{"issue":"5","key":"81526_CR29","doi-asserted-by":"publisher","first-page":"e019130","DOI":"10.1161\/JAHA.120.019130","volume":"10","author":"ZK Law","year":"2021","unstructured":"Law, Z. K. et al. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial. J. Am. Heart Assoc. 10 (5), e019130. https:\/\/doi.org\/10.1161\/JAHA.120.019130 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"81526_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng, S. L. & Roddick, A. J. Association of Aspirin Use for primary Prevention with Cardiovascular events and bleeding events: a systematic review and Meta-analysis. JAMA 321 (3), 277\u2013287. https:\/\/doi.org\/10.1001\/jama.2018.20578 (2019).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81526-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T01:04:33Z","timestamp":1732842273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81526-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81526"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81526-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"the study has obtained approval from the Ethical Committee of the University of L\u2019Aquila (protocol numbers 13\/2018 and 57\/2019). All subjects gave written informed consent for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29664"}}